HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Cardiology World Conference

September 5-7, 2024 | Madrid, Spain

September 05 -07, 2024 | Madrid, Spain

Cardio 2024

Robert J Chilton, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Robert J Chilton, UT Health San Antonio, United States

Atherothrombotic disease, characterized by the formation of atherosclerotic plaques leading to arterial thrombosis, is a significant cause of morbidity and mortality worldwide. Despite considerable progress in therapeutic interventions, there remains an unmet need for novel treat [....] » Read More

Yong Xiao Wang, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

Pulmonary hypertension (PH) is a common and devastating lung disease. The current primary interventions for this disease are to use non-specific vasodilators, but patients do not always respond well to these non-specific vasodilators. Voltage-dependent potassium channels and stor [....] » Read More

Naranjan Dhalla, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada

Although different antiplatelet agents are used for the prevention of thrombosis and treatment of ischemic heart disease, very little information regarding therapeutic potential of these agents in heart failure is available. We have investigated the effects of some antiplatelet a [....] » Read More

Kaifu Chen, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Kaifu Chen, Cardiology Department, Boston Children’s Hospital, Boston, MA, USA, United States

A cell type is determined by the network function of its cell identity genes, including master transcription factors that govern the expression status of this network. Cell identity transition is fundamental in normal differentiation and development, whereas a cell that loses its [....] » Read More

Alaa A Sayed, Speaker at Heart Conferences
Oral Presentation (In-Person)
Alaa A Sayed, UPMC, United States

Introduction: Atrial fibrillation accounts for one-sixth of all strokes, potentially leading to significant disability and death. The left atrial appendage (LAA) is the most common location for thrombus formation that can cause ischemic strokes. Excluding the LAA has been hypothe [....] » Read More

Jose Maria Castellano Vazquez, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Jose Maria Castellano Vazquez, National Center for Cardiovascular Research (CNIC), Spain

Background: The incidence of recurrent cardiovascular (CV) events (CVe) and all-cause mortality is high among patients in secondary prevention. The SECURE trial demonstrated that the CNIC-Polypill Strategy combining acetylsalicylic acid [ASA], atorvastatin and ramipril into a sin [....] » Read More

Osama ElmaraghI, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Osama ElmaraghI, MOH Kuwait, Kuwait

Heart failure is a clinical syndrome caused by a structural and/or functional cardiac abnormality, resulting in a reduced cardiac output and/or elevated intracardiac pressures at rest or during stress.1 Heart failure poses a significant global disease burden, more than 60 million [....] » Read More

Kimberly L Co, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Kimberly L Co, Cardinal Santos Medical Center, Philippines

Background: Erectile Dysfunction (ED) is an important worldwide health issue that affects nearly half of men over the age of 40 years. It has a significant negative impact on the quality of life and life satisfaction of the affected individual as well as his partner. The primary [....] » Read More

Marc Jason Ng, Speaker at Heart Conferences
Oral Presentation (In-Person)
Marc Jason Ng, Cardinal Santos Medical Center, Philippines

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are principally known as agents for the control of Type 2 diabetes mellitus (Type 2 DM). In recent years, they have gained more attention, especially for their role in cardiovascular protection in Type 2 diabetes patie [....] » Read More

Susy Kotit, Speaker at Cardiology Conference
Oral Presentation (In-Person)
Susy Kotit, Aswan Heart Centre, Egypt

During the presentation, the epidemiology and background of Rheumatic Heart Disease (RHD), with attention to statistics, global burden, and consequences will shortly be presented, followed by data on the resurgence of the disease in areas where it was previously eradicated.  [....] » Read More

Cynthia Okafor, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Cynthia Okafor, University of Texas Medical Branch, United States

Hypertrophic cardiomyopathy is a disease of the myocardium with an autosomal dominant inheritance pattern. Its primary cause is a mutation in the cardiac sarcomere proteins with contractile function. A defining feature and major hallmark of the disease is a left ventricular obstr [....] » Read More

Alaa A Sayed, Speaker at Heart Conferences
Poster Presentation (In-Person)
Alaa A Sayed, UPMC, United States

The patient is a 54-year-old female with past medical history of Dilation and curettage (D&C) who presented with left sided monocular vision loss 5 months prior to admission. She was evaluated by stroke with comprehensive workup that has been negative. She obtained TTE was si [....] » Read More

Lianne Marie R Ramos, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Lianne Marie R Ramos, Cardinal Santos Medical Center, Philippines

Coronary cameral fistulae are occasionally incidental findings present in less than 1% of the population and 0.1%-0.2% of coronary angiographic studies. In children, coronary artery fistulae account for around half of coronary vasculature anomalies. Most commonly, these drain fro [....] » Read More

Nima, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Nima, Iran University of Medical Sciences, Iran (Islamic Republic of)

Background: Periprocedural myocardial injury is a predictor of cardiovascular morbidity and mortality after percutaneous coronary intervention. Methods: The authors examined the effects of preprocedural lipid levels (low-density lipoprotein, high-density lipoprotein, [....] » Read More

Mekhman N Mamedov, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation

The aim: of the study is to analyze the risk of cardiovascular complications (CVC) in an unorganized population of men and women of working age in the Vladimir region. Material and methods: The cross-sectional population-based study included 1,350 men and women aged [....] » Read More

Victor O Adedara, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Victor O Adedara, St George’s University School of Medicine, Grenada

Non-communicable diseases, especially cardiovascular diseases (CVD), present a global health challenge, with a disproportionate impact on low and middle-income countries. The majority of global deaths, amounting to 71%, are attributed to non-communicable diseases, with 78% occurr [....] » Read More

Nahid Mobasser, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Nahid Mobasser, ZUMS, Iran (Islamic Republic of)

Background: Furosemide is a type of medicine known as a diuretic. It is used to treat high blood pressure (hypertension), heart failure, and a buildup of fluid in the body. Furosemide works by acting on the kidneys to increase the flow of urine. This helps to lower blood pre [....] » Read More

Maria Borrell, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Maria Borrell, Institut de Recerca Sant Pau - Centre CERCA, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

Hela Guerram, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Hela Guerram, South Francilien Hospital Center, France

Introduction: Lyme carditis has been reported in 1 to 5% of diagnosed patients with Lyme disease. The most common presentation of Lyme carditis is conduction system disturbances such as atrioventricular (AV) block. Case Summary: We report the case of a 35-year-old [....] » Read More

Dilnoza Tagaeva, Speaker at Heart Conferences
Poster Presentation (Virtual)
Dilnoza Tagaeva, Republican Specialized Scientific and Practical Medical Center for Therapy and Medical Rehabilitation, Uzbekistan

Purpose of the study: To study the features of cardiac remodeling depending on the degree of kidney dysfunction. Left ventricular ejection fraction (LVEF) in CHF with kidney  dysfunction (KD).  Materials and methods of research: A comprehensive examination of 15 [....] » Read More

Maheswara Satya, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Maheswara Satya, Guam Regional Medical City, United States

Background:Approximately 20.1 million adults in the United States are affected by coronary artery disease. Every year over 4 million coronary angiograms are being performed in Europe and the USA. Over 1700 cardiac catheterization laboratories were present across the United States [....] » Read More

Will be updated soon......